E-LIB Suche - Ergebnisse für: Fulcher, G.

1

EE304 IDegAsp Treatment Was Associated with Reduced Healthc..:

Alturaiki, A ; Al-Suwairi, M ; Akhtar, S...
Value in Health. 25 (2022) 7 - p. S393 , 2022

Link: https://doi.org/10.1016/..

2

IDF21-0675 IDegAsp treatment was associated with improved g..:

Fulcher, G. ; Akhtar, S. ; Al-Jaser, S.J....
Diabetes Research and Clinical Practice. 186 (2022) - p. 109618 , 2022

Link: https://doi.org/10.1016/..

3

IDF21-0676 IDegAsp treatment in adults with type 2 diabetes..:

Kok, A. ; Al-Jaser, S.J. ; Biradar, A....
Diabetes Research and Clinical Practice. 186 (2022) - p. 109619 , 2022

Link: https://doi.org/10.1016/..

4

IDF21-0673 IDegAsp treatment in adults with type 2 diabetes..:

Fulcher, G. ; Al-Jaser, S.J. ; Medina, J....
Diabetes Research and Clinical Practice. 186 (2022) - p. 109617 , 2022

Link: https://doi.org/10.1016/..

5

SUN-129 ACTIVATION LEVELS AMONG PATIENTS WITH COMORBID DIAB..:

ZIMBUDZI BSN, E. ; Lo, C. ; Ranasinha, S....
Kidney International Reports. 5 (2020) 3 - p. S255 , 2020

Link: https://doi.org/10.1016/..

6

SUN-128 A CO-DESIGNED INTEGRATED DIABETES AND KIDNEY DISEAS..:

ZIMBUDZI BSN, E. ; Lo, C. ; Sanjeeva, R....
Kidney International Reports. 5 (2020) 3 - p. S255 , 2020

Link: https://doi.org/10.1016/..

7

SUN-266 HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH ..:

ZIMBUDZI BSN, E. ; Lo, C. ; Teede, H....
Kidney International Reports. 4 (2019) 7 - p. S270 , 2019

Link: https://doi.org/10.1016/..

8

Gaps and barriers in health-care provision for co-morbid di..:

Lo, C. ; Teede, H. ; Fulcher, G....
BMC Nephrology. 18 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

9

Left Atrial Strain in Obese, Type 2 Diabetic Patients by Ma..:

Evin, M. ; Broadhouse, K. ; Callaghan, F....
Heart, Lung and Circulation. 25 (2016) - p. S239-S240 , 2016

Link: https://doi.org/10.1016/..

10

Healthcare professional requirements for the care of adult ..:

Xu, S. ; Alexander, K. ; Bryant, W....
Internal Medicine Journal. 45 (2015) 1 - p. 86-93 , 2015

Link: https://doi.org/10.1111/..

11

Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) ..:

Heesen, C. ; Kasper, J. ; Fischer, K....
PLOS ONE. 10 (2015) 10 - p. e0138364 , 2015

Link: https://doi.org/10.1371/..

12

Efficacy and safety of canagliflozin when used in conjuncti..:

Fulcher, G. ; Matthews, D. R. ; Perkovic, V....
Diabetes, Obesity and Metabolism. 18 (2015) 1 - p. 82-91 , 2015

Link: https://doi.org/10.1111/..

13

PO415 GREATER PPG CONTROL ACROSS ALL 3 MAIN MEALS WITH LIRA..:

Fulcher, G. ; Shomali, M. ; Blonde, L....
Diabetes Research and Clinical Practice. 106 (2014) - p. S257 , 2014

Link: https://doi.org/10.1016/..

14

PO416 LIRAGLUTIDE MONOTHERAPY PROVIDES SUPERIOR PPG CONTROL..:

Fulcher, G. ; Bailey, T. ; Bode, B....
Diabetes Research and Clinical Practice. 106 (2014) - p. S257-S258 , 2014

Link: https://doi.org/10.1016/..

15

PO083 PRACTICAL GUIDANCE ON THE USE OF PREMIX INSULIN ANALO..:

Wu, T. ; Betty, B. ; Downie, M....
Diabetes Research and Clinical Practice. 106 (2014) - p. S87 , 2014

Link: https://doi.org/10.1016/..